Cannabinoid receptor gene polymorphisms and bone mineral density in Korean postmenopausal women

Menopause

Volumn 22, Issue 5, 2015, Pages 512-519

  Woo, Jae Hee ^a   Kim, Hoon ^b,c   Kim, Jong Hak ^a   Kim, Jung Gu ^b,c  

^a Ewha Womans University   (South Korea)

^b Seoul National University   (South Korea)

^c Seoul National University Hospital   (South Korea)

Author keywords

Bone density; Bone markers; Cannabinoid receptors; Polymorphism

Indexed keywords

CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CANNABINOID RECEPTOR; OSTEOPROTEGERIN; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; CNR1 PROTEIN, HUMAN; CNR2 PROTEIN, HUMAN; OSTEOCLAST DIFFERENTIATION FACTOR;

ADULT; AGED; ARTICLE; BODY MASS; BONE DENSITY; BONE MASS; BONE TURNOVER; DNA POLYMORPHISM; FEMALE; FEMUR NECK; GENE LINKAGE DISEQUILIBRIUM; GENOTYPE; HUMAN; LUMBAR SPINE; MAJOR CLINICAL STUDY; OSTEOPOROSIS; POSTMENOPAUSE; SINGLE NUCLEOTIDE POLYMORPHISM; BLOOD; GENETICS; LUMBAR VERTEBRA; MIDDLE AGED; SOUTH KOREA;

BONE DENSITY; FEMALE; FEMUR NECK; GENOTYPE; HUMANS; LUMBAR VERTEBRAE; MIDDLE AGED; OSTEOPROTEGERIN; POLYMORPHISM, SINGLE NUCLEOTIDE; POSTMENOPAUSE; RANK LIGAND; RECEPTOR, CANNABINOID, CB1; RECEPTOR, CANNABINOID, CB2; REPUBLIC OF KOREA;

EID: 84929043348     PISSN: 10723714     EISSN: 15300374     Source Type: Journal    
DOI: 10.1097/GME.0000000000000339     Document Type: Article

References (29)

1. Kanis JA, Melton LJ III, Christiansen C, Johnston CC, Khaltaev N. The diagnosis of osteoporosis. J Bone Miner Res 1994;9:1137-1141.
2. Martin TJ. Historically significant events in the discovery of RANK/ RANKL/OPG. World J Orthop 2013:186-197.
3. Jouanny P, Guillemin F, Kuntz C, Jeandel C, Pourel J. Environmental and genetic factors affecting bone mass. Similarity of bone density among members of healthy families. Arthritis Rheum 1995;38:61-67.
4. Gong G, Haynatzki G. Association between bone mineral density and candidate genes in different ethnic populations and its implications. Calcif Tissue Int 2003;72:113-123.
5. Hosoi T. Genetic aspects of osteoporosis. J Bone Miner Metab 2010; 28:601-607.
6. Richards JB, Kavvoura FK, Rivadeneira F, et al. Collaborative metaanalysis: associations of 150 candidate genes with osteoporosis and osteoporotic fracture. Ann Intern Med 2009;151:528-537.
7. Kim JG, Lim KS, Kim EK, Choi YM, Lee JY. Association of vitamin D receptor and estrogen receptor gene polymorphisms with bone mass in postmenopausal Korean women. Menopause 2001;8:222-228.
8. Kim JG, Roh KR, Lee JY. The relationship among serum insulin-like growth factor-I, insulin-like growth factor-I gene polymorphism and bone mineral density in postmenopausal women in Korea. Am J Obstet Gynecol 2002;186:345-350.
9. Kim JG, Kwon JH, Kim SH, Choi YM, Moon SY, Lee JY. Association between vitamin D receptor gene haplotypes and bone mass in postmenopausal Korean women. Am J Obstet Gynecol 2003;189:1234-1240.
10. Kim JG, Kim JH, Kim JY, et al. Association between osteoprotegerin (OPG), receptor activator of nuclear factor-JB (RANK), and RANK ligand (RANKL) gene polymorphisms and circulating OPG, soluble RANKL levels, and bone mineral density in Korean postmenopausal women. Menopause 2007;14:913-918.
11. Kim H, Chun S, Ku SY, Suh CS, Choi YM, Kim JG. Association between polymorphisms in tumor necrosis factor (TNF) and TNF receptor genes and circulating TNF, soluble TNF receptor levels, and bone mineral density in postmenopausal Korean women. Menopause 2009;16: 1014-1020.
12. Lee DY, Kim H, Ku SY, Kim SH, Choi YM, Kim JG. Association between polymorphisms in Wnt signaling pathway genes and bone mineral density in postmenopausal Korean women. Menopause 2010;17: 1064-1070.
13. Idris AI, Ralston SH. Role of cannabinoids in the regulation of bone remodeling. Front Endocrinol (Lausanne) 2012;3:136.
14. Bab I, Zimmer A. Cannabinoid receptors and the regulation of bone mass. Br J Pharmacol 2008;153:182-188.
15. Bab I, Ofek O, Tam J, Rehnelt J, Zimmer A. Endocannabinoids and the regulation of bone metabolism. J Neuroendocrinol 2008;20(suppl 1): 69-74.
16. Idris AI, van't Hof RJ, Greig IR, et al. Regulation of bone mass, bone loss and osteoclast activity by cannabinoid receptors. Nat Med 2005; 11:774-779.
17. Sophocleous A, Landao-Bassonga E, van't Hof RJ, Idris AI, Ralston SH. The type 2 cannabinoid receptor regulates bone mass and ovariectomyinduced bone loss by affecting osteoblast differentiation and bone formation. Endocrinology 2011;152:2141-2149.
18. Qian H, Zhao Y, Peng Y, et al. Activation of cannabinoid receptor CB2 regulates osteogenic and osteoclastogenic gene expression in human periodontal ligament cells. J Periodontal Res 2010;45:504-511.
19. Napimoga MH, Benatti BB, Lima FO, et al. Cannabidiol decreases bone resorption by inhibiting RANK/RANKL expression and proinflammatory cytokines during experimental periodontitis in rats. Int Immunopharmacol 2009;9:216-222.
20. Geng DC, Xu YZ, Yang HL, Zhu GM, Wang XB, Zhu XS. Cannabinoid receptor-2 selective antagonist negatively regulates receptor activator of nuclear factor JB ligand mediated osteoclastogenesis. Chin Med J (Engl) 2011;124:586-590.
21. Yamada Y, Ando F, Shimokata H. Association of candidate gene polymorphisms with bone mineral density in community-dwelling Japanese women and men. Int J Mol Med 2007;19:791-801.
22. Karsak M, Cohen-Solal M, Freudenberg J, et al. Cannabinoid receptor type 2 gene is associated with human osteoporosis. Hum Mol Genet 2005;14:3389-3396.
23. Karsak M, Malkin I, Toliat MR, et al. The cannabinoid receptor type 2 (CNR2) gene is associated with hand bone strength phenotypes in an ethnically homogeneous family sample. Hum Genet 2009;126:629-636.
24. Huang QY, Li GH, Kung AW. Multiple osteoporosis susceptibility genes on chromosome 1p36 in Chinese. Bone 2009;44:984-988.
25. Vasileiou I, Fotopoulou G, Matzourani M, Patsouris E, Theocharis S. Evidence for the involvement of cannabinoid receptors' polymorphisms in the pathophysiology of human diseases. Expert Opin Ther Targets 2013;17:363-377.
26. Devoto M, Specchia C, Li HH, et al. Variance component linkage analysis indicates a QTL for femoral neck bone mineral density on chromosome 1p36. Hum Mol Genet 2001;10:2447-2452.
27. Carrasquer A, Nebane NM, Williams WM, Song ZH. Functional consequences of nonsynonymous single nucleotide polymorphisms in the CB2 cannabinoid receptor. Pharmacogenet Genomics 2010;20: 157-166.
28. Sipe JC, Arbour N, Gerber A, Beutler E. Reduced endocannabinoid immune modulation by a common cannabinoid 2 (CB2) receptor gene polymorphism: possible risk for autoimmune disorders. J Leukoc Biol 2005;78:231-238.
29. Gazzola L, Bellistri GM, Tincati C, et al. Association between peripheral T-lymphocyte activation and impaired bone mineral density in HIVinfected patients. J Transl Med 2013;11:51.